This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of LINZESS 72 MCG capsules, a prescription medication. The award is a firm fixed-price Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999, which enables DLA to efficiently procure a comprehensive range of medical commodities from AmerisourceBergen to support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,102.22 firm fixed-price delivery order is for the supply of LINZESS 145 MCG CAPSULE medical products, with a period of performance through November 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide LINZESS 290 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $1,484.48. The ultimate completion date is July 29, 2024. This appears to be a contract under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that Amerisourcebergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of LINZESS 290 MCG capsules. The contract, valued at $10,503.06, is a firm fixed-price delivery order issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract is for the delivery of pharmaceutical products to support military treatment programs and facilities...
This federal contract award, valued at $1,239.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 17, 2025. The contract provides for the delivery of LINZESS 72 MCG CAPSULE UU 30S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,280.72 firm fixed-price contract is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a prescription medication. The contract has an ultimate completion date of June 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,587.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 72 MCG CAPSULE UU 30S. The contract has a firm fixed price of $2,486.84 and a completion date of June 18, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,548.04 fixed-price contract is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a prescription medication, with a performance period ending on June 18, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA...
This federal contract award, valued at $3,239.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of LINZESS 145 MCG CAPSULE UU 30S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., will supply these essential pharmaceutical products to...